A detailed history of Axa S.A. transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Axa S.A. holds 207,980 shares of IDYA stock, worth $5.57 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
207,980
Previous 243,484 14.58%
Holding current value
$5.57 Million
Previous $8.55 Million 22.93%
% of portfolio
0.02%
Previous 0.03%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$30.37 - $43.05 $1.08 Million - $1.53 Million
-35,504 Reduced 14.58%
207,980 $6.59 Million
Q2 2024

Aug 14, 2024

BUY
$34.37 - $43.46 $4,674 - $5,910
136 Added 0.06%
243,484 $8.55 Million
Q1 2024

May 15, 2024

BUY
$34.2 - $47.13 $2,325 - $3,204
68 Added 0.03%
243,348 $10.7 Million
Q4 2023

Jul 16, 2024

SELL
$24.59 - $35.83 $1,672 - $2,436
-68 Reduced 0.03%
243,280 $8.66 Million
Q4 2023

Feb 14, 2024

SELL
$24.59 - $35.83 $2.47 Million - $3.6 Million
-100,475 Reduced 29.23%
243,280 $8.66 Million
Q3 2023

Nov 14, 2023

SELL
$21.07 - $29.77 $25,410 - $35,902
-1,206 Reduced 0.35%
343,755 $9.27 Million
Q2 2023

Aug 14, 2023

BUY
$13.33 - $25.53 $63,250 - $121,139
4,745 Added 1.39%
344,961 $8.11 Million
Q1 2023

May 15, 2023

SELL
$13.49 - $18.72 $10,157 - $14,096
-753 Reduced 0.22%
340,216 $4.67 Million
Q4 2022

Feb 14, 2023

SELL
$14.47 - $18.17 $1.28 Million - $1.6 Million
-88,149 Reduced 20.54%
340,969 $6.2 Million
Q3 2022

Feb 14, 2023

BUY
$9.24 - $15.79 $17,278 - $29,527
1,870 Added 0.44%
429,118 $6.4 Million
Q3 2022

Nov 14, 2022

BUY
$9.24 - $15.79 $17,278 - $29,527
1,870 Added 0.44%
429,118 $6.4 Million
Q2 2022

Feb 14, 2023

BUY
$8.28 - $13.88 $1.2 Million - $2.01 Million
145,144 Added 51.45%
427,248 $5.9 Million
Q2 2022

Aug 15, 2022

BUY
$8.28 - $13.88 $1.2 Million - $2.01 Million
145,144 Added 51.45%
427,248 $5.9 Million
Q1 2022

Feb 14, 2023

SELL
$11.18 - $24.02 $1.64 Million - $3.53 Million
-147,014 Reduced 34.26%
282,104 $3.16 Million
Q1 2022

May 13, 2022

BUY
$11.18 - $24.02 $22 - $48
2 Added 0.0%
282,104 $3.16 Million
Q4 2021

Feb 14, 2022

BUY
$20.95 - $26.88 $70,580 - $90,558
3,369 Added 1.21%
282,102 $6.67 Million
Q3 2021

Nov 15, 2021

BUY
$17.26 - $27.08 $666,684 - $1.05 Million
38,626 Added 16.09%
278,733 $7.11 Million
Q2 2021

Aug 13, 2021

BUY
$17.76 - $24.83 $4.26 Million - $5.96 Million
240,107 New
240,107 $5.04 Million

Others Institutions Holding IDYA

About IDEAYA Biosciences, Inc.


  • Ticker IDYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,067,700
  • Market Cap $1.29B
  • Description
  • IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...
More about IDYA
Track This Portfolio

Track Axa S.A. Portfolio

Follow Axa S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.